back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-10-03 17:11 Tx date 2023-09-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+14,768 vol |
14,768 | |
| Filed 2023-09-25 10:02 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$39,777
+13,259 vol $3.00 each |
13,259 | |
| Filed 2023-09-25 10:02 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-17,387 vol |
0 | |
| Filed 2023-09-25 10:01 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-13,259 vol |
||
| Filed 2023-09-25 10:01 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-4,128 vol |
||
| Filed 2023-09-25 10:01 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$39,777
+13,259 vol $3.00 each |
||
| Filed 2023-09-25 09:31 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$39,777
+13,259 vol $3.00 each |
13,259 | |
| Filed 2023-09-25 09:31 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$39,777
+13,259 vol $3.00 each |
||
| Filed 2023-09-25 09:29 Tx date 2023-02-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-25 09:29 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-13,259 vol |
||
| Filed 2023-09-25 09:29 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-13,259 vol |
0 | |
| Filed 2023-09-25 09:28 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-4,128 vol |
13,259 | |
| Filed 2023-09-25 09:28 Tx date 2023-09-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-4,128 vol |
||
| Filed 2023-03-21 18:47 Tx date 2023-03-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+34,774 vol |
34,774 | |
| Filed 2023-03-21 18:47 Tx date 2023-02-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-21 18:47 Tx date 2023-03-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,387 vol |
17,387 | |
| Filed 2023-03-21 18:46 Tx date 2023-02-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|